Life Sciences Legal Review - Spring 2014
Welcome to our second Life Sciences Legal Review. We hope that this edition will provide something of interest for everybody in the field, ranging from research based companies to manufacturers and distributors.
If you have any topics you would like covered in future editions please let us know – if a topic is of interest to you than it is likely to be of interest to others.
News & Insights
What does the Bawa-Garba case mean for pharmacists?
David Reissner examines what pharmacists can take from the Bawa-Garba case that has rocked medicine.